Franck E. Nicolini

Interferon Alfa-2b Combined with Cytarabine versus Interferon Alone in Chronic Myelogenous Leukemia

François Guilhot, Claude Chastang, Mauricette Michallet et al. · New England Journal of Medicine · 1997 · 553 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

BCR-ABL1 Compound Mutations Combining Key Kinase Domain Positions Confer Clinical Resistance to Ponatinib in Ph Chromosome-Positive Leukemia

Matthew S. Zabriskie, Christopher A. Eide, Srinivas K. Tantravahi et al. · Cancer Cell · 2014 · 366 citations · Full text

Medicine, Molecular Biology, Oncology +7

Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow

Tessa L. Holyoake, Franck E. Nicolini, Connie J. Eaves · Experimental Hematology · 1999 · 259 citations

Life Sciences, Cell Biology, Hematology +17

Ponatinib versus imatinib for newly diagnosed chronic myeloid leukaemia: an international, randomised, open-label, phase 3 trial

Jeffrey H. Lipton, Charles Chuah, Agnès Guerci‐Bresler et al. · The Lancet Oncology · 2016 · 259 citations

Medicine, Hematology, Pharmacology +6

Evidence that Resistance to Nilotinib May Be Due to BCR-ABL, Pgp, or Src Kinase Overexpression

François‐Xavier Mahon, Sandrine Hayette, Valérie Lagarde et al. · Cancer Research · 2008 · 210 citations

Medicine, Oncology, Pharmacology +14